Montelukast sodium is under clinical development by Jiangyin Berrysen Pharmaceutical and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II drugs for Endometrial Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback